Status:
COMPLETED
Impact of Rapid Screening for COVID-19 in Delocalized Biology in the Emergency Department
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, first appeared in China, and then spread around the world. In December 2019, a group of patients with pneumonia of unknown origin were infect...
Detailed Description
Early detection with a sensitive technique of COVID-19 is essential to ensure rapid and appropriate patient management, to contain the epidemic and to better understand the global epidemiology of the ...
Eligibility Criteria
Inclusion
- Patient aged ≥ 18 years
- Patient presenting to the emergency unit of the GhPSJ and for whom a PCR examination is prescribed by the emergency doctor in charge of the patient
- French-speaking patient
Exclusion
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient under legal protection
- Patient objecting to the use of their data for this research.
Key Trial Info
Start Date :
February 24 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 6 2022
Estimated Enrollment :
2488 Patients enrolled
Trial Details
Trial ID
NCT04786249
Start Date
February 24 2021
End Date
May 6 2022
Last Update
May 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, Île-de-France Region, France, 75014